Publications in collaboration with researchers from Free University of Berlin (1)

2023

  1. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

    The Lancet, Vol. 401, Núm. 10391, pp. 1853-1865